Clinical Trial Update: An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial comparing esomeprazole and lansoprazole in Barrett's Esophagus patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus

Drugs mentioned

• Nexium (esomeprazole)
• PREVACID (LANSOPRAZOLE)

Snippet

Sponsor: AstraZeneca | Conditions: Barrett's Esophagus | Phase 4 | Status: COMPLETED